IDOVEN is a health technology company founded in 2018 that develops artificial intelligence tools for cardiology. Its work centres on early detection and precision medicine for cardiovascular diseases, applying deep learning techniques to clinical use cases. The company operates primarily in Europe.
Its main product, Willem, is a cloud-based AI platform that analyses electrocardiograms (ECGs) from any device. The platform, which carries a CE mark, helps clinicians detect 22 cardiac patterns and measure four key intervals, including PR, QT, and QRS duration. IDOVEN describes it as the world's first cardiology-as-a-service platform powered by artificial intelligence.
The company's AI models are trained on a substantial dataset comprising over 1.8 million ECG hours from more than 28,500 subjects. Its research has resulted in 35 publications in top-tier scientific journals. IDOVEN collaborates with established medical technology and pharmaceutical companies, including AstraZeneca, Abbott, GE Healthcare, and Medtronic.
